185 related articles for article (PubMed ID: 27508872)
1. Loss of Function of GALNT2 Lowers High-Density Lipoproteins in Humans, Nonhuman Primates, and Rodents.
Khetarpal SA; Schjoldager KT; Christoffersen C; Raghavan A; Edmondson AC; Reutter HM; Ahmed B; Ouazzani R; Peloso GM; Vitali C; Zhao W; Somasundara AV; Millar JS; Park Y; Fernando G; Livanov V; Choi S; Noé E; Patel P; Ho SP; ; Kirchgessner TG; Wandall HH; Hansen L; Bennett EP; Vakhrushev SY; Saleheen D; Kathiresan S; Brown CD; Abou Jamra R; LeGuern E; Clausen H; Rader DJ
Cell Metab; 2016 Aug; 24(2):234-45. PubMed ID: 27508872
[TBL] [Abstract][Full Text] [Related]
2. A novel role for GalNAc-T2 dependent glycosylation in energy homeostasis.
Verzijl CRC; Oldoni F; Loaiza N; Wolters JC; Rimbert A; Tian E; Yang W; Struik D; Smit M; Kloosterhuis NJ; Fernandez AJ; Samara NL; Ten Hagen KG; Dalal K; Chernish A; McCluggage P; Tabak LA; Jonker JW; Kuivenhoven JA
Mol Metab; 2022 Jun; 60():101472. PubMed ID: 35304331
[TBL] [Abstract][Full Text] [Related]
3. GALNT2 regulates ANGPTL3 cleavage in cells and in vivo of mice.
Li X; Zhang Y; Zhang M; Wang Y
Sci Rep; 2020 Sep; 10(1):16168. PubMed ID: 32999434
[TBL] [Abstract][Full Text] [Related]
4. GALNT2 effect on HDL-cholesterol and triglycerides levels in humans: Evidence of pleiotropy?
Di Paola R; Marucci A; Trischitta V
Nutr Metab Cardiovasc Dis; 2017 Apr; 27(4):281-282. PubMed ID: 28153384
[TBL] [Abstract][Full Text] [Related]
5. ANGPTL3 is part of the machinery causing dyslipidemia majorily via LPL inhibition in mastitis mice.
Xiao HB; Wang JY; Sun ZL
Exp Mol Pathol; 2017 Dec; 103(3):242-248. PubMed ID: 29104012
[TBL] [Abstract][Full Text] [Related]
6. Looking beyond GWAS: allele-specific transcription factor binding drives the association of GALNT2 to HDL-C plasma levels.
Cavalli M; Pan G; Nord H; Wadelius C
Lipids Health Dis; 2016 Jan; 15():18. PubMed ID: 26817450
[TBL] [Abstract][Full Text] [Related]
7. Paeoniflorin regulates GALNT2-ANGPTL3-LPL pathway to attenuate dyslipidemia in mice.
Xiao HB; Liang L; Luo ZF; Sun ZL
Eur J Pharmacol; 2018 Oct; 836():122-128. PubMed ID: 30096295
[TBL] [Abstract][Full Text] [Related]
8. O-glycosylation modulates proprotein convertase activation of angiopoietin-like protein 3: possible role of polypeptide GalNAc-transferase-2 in regulation of concentrations of plasma lipids.
Schjoldager KT; Vester-Christensen MB; Bennett EP; Levery SB; Schwientek T; Yin W; Blixt O; Clausen H
J Biol Chem; 2010 Nov; 285(47):36293-303. PubMed ID: 20837471
[TBL] [Abstract][Full Text] [Related]
9. Novel roles of hepatic lipase and phospholipid transfer protein in VLDL as well as HDL metabolism.
van Haperen R; Samyn H; van Gent T; Zonneveld AJ; Moerland M; Grosveld F; Jansen H; Dallinga-Thie GM; van Tol A; de Crom R
Biochim Biophys Acta; 2009 Oct; 1791(10):1031-6. PubMed ID: 19524061
[TBL] [Abstract][Full Text] [Related]
10. Characterization of three kindreds with familial combined hypolipidemia caused by loss-of-function mutations of ANGPTL3.
Pisciotta L; Favari E; Magnolo L; Simonelli S; Adorni MP; Sallo R; Fancello T; Zavaroni I; Ardigò D; Bernini F; Calabresi L; Franceschini G; Tarugi P; Calandra S; Bertolini S
Circ Cardiovasc Genet; 2012 Feb; 5(1):42-50. PubMed ID: 22062970
[TBL] [Abstract][Full Text] [Related]
11. Leveraging Genetics to Address the Role of GALNT2 on Atherogenic Dyslipidemia.
Di Paola R; Marucci A; Mangiacotti D; Antonucci A; Fontana A; Wang X; Qi L; Menzaghi C; Trischitta V
Adv Biol (Weinh); 2023 Sep; 7(9):e2200319. PubMed ID: 36861373
[TBL] [Abstract][Full Text] [Related]
12. Increased prebeta-high density lipoprotein, apolipoprotein AI, and phospholipid in mice expressing the human phospholipid transfer protein and human apolipoprotein AI transgenes.
Jiang X; Francone OL; Bruce C; Milne R; Mar J; Walsh A; Breslow JL; Tall AR
J Clin Invest; 1996 Nov; 98(10):2373-80. PubMed ID: 8941656
[TBL] [Abstract][Full Text] [Related]
13. ANGPTL3 serum concentration and rare genetic variants in Finnish population.
Tikka A; Metso J; Jauhiainen M
Scand J Clin Lab Invest; 2017 Dec; 77(8):601-609. PubMed ID: 28972399
[TBL] [Abstract][Full Text] [Related]
14.
Qaddoumi M; Hebbar P; Abu-Farha M; Al Somaly A; Melhem M; Al-Kayal F; AlKhairi I; Cherian P; Alanbaei M; Al-Mulla F; Abubaker J; Thanaraj TA
Genes (Basel); 2022 Jul; 13(7):. PubMed ID: 35885984
[TBL] [Abstract][Full Text] [Related]
15. Novel congenital disorder of O-linked glycosylation caused by GALNT2 loss of function.
Zilmer M; Edmondson AC; Khetarpal SA; Alesi V; Zaki MS; Rostasy K; Madsen CG; Lepri FR; Sinibaldi L; Cusmai R; Novelli A; Issa MY; Fenger CD; Abou Jamra R; Reutter H; Briuglia S; Agolini E; Hansen L; Petäjä-Repo UE; Hintze J; Raymond KM; Liedtke K; Stanley V; Musaev D; Gleeson JG; Vitali C; O'Brien WT; Gardella E; Rubboli G; Rader DJ; Schjoldager KT; Møller RS
Brain; 2020 Apr; 143(4):1114-1126. PubMed ID: 32293671
[TBL] [Abstract][Full Text] [Related]
16. Fenofibrate reverses the decline in HDL cholesterol in mice overexpressing human phospholipid transfer protein.
Lie J; Lankhuizen IM; Gross B; van Gent T; van Haperen R; Scheek L; Staels B; de Crom R; van Tol A
Biochim Biophys Acta; 2005 Dec; 1738(1-3):48-53. PubMed ID: 16298159
[TBL] [Abstract][Full Text] [Related]
17. Multiple Hepatic Regulatory Variants at the GALNT2 GWAS Locus Associated with High-Density Lipoprotein Cholesterol.
Roman TS; Marvelle AF; Fogarty MP; Vadlamudi S; Gonzalez AJ; Buchkovich ML; Huyghe JR; Fuchsberger C; Jackson AU; Wu Y; Civelek M; Lusis AJ; Gaulton KJ; Sethupathy P; Kangas AJ; Soininen P; Ala-Korpela M; Kuusisto J; Collins FS; Laakso M; Boehnke M; Mohlke KL
Am J Hum Genet; 2015 Dec; 97(6):801-15. PubMed ID: 26637976
[TBL] [Abstract][Full Text] [Related]
18. Heterozygosity for a loss-of-function mutation in GALNT2 improves plasma triglyceride clearance in man.
Holleboom AG; Karlsson H; Lin RS; Beres TM; Sierts JA; Herman DS; Stroes ES; Aerts JM; Kastelein JJ; Motazacker MM; Dallinga-Thie GM; Levels JH; Zwinderman AH; Seidman JG; Seidman CE; Ljunggren S; Lefeber DJ; Morava E; Wevers RA; Fritz TA; Tabak LA; Lindahl M; Hovingh GK; Kuivenhoven JA
Cell Metab; 2011 Dec; 14(6):811-8. PubMed ID: 22152306
[TBL] [Abstract][Full Text] [Related]
19. Adipocyte phospholipid transfer protein and lipoprotein metabolism.
Jiang H; Yazdanyar A; Lou B; Chen Y; Zhao X; Li R; Hoang Bui H; Kuo MS; Navab M; Qin S; Li Z; Jin W; Jiang XC
Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):316-22. PubMed ID: 25477345
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of links between high-density lipoprotein genetics, functionality, and aortic valve stenosis risk in humans.
Arsenault BJ; Dubé MP; Brodeur MR; de Oliveira Moraes AB; Lavoie V; Kernaleguen AE; Guauque-Olarte S; Mathieu P; Pibarot P; Messika-Zeitoun D; Bossé Y; Rhainds D; Rhéaume E; Tardif JC
Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):457-62. PubMed ID: 24334872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
